Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.
GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Elizabeth Plimack discussing two abstracts: “Adjuvant nivolumab vs placebo for high-risk ...
Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.
Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. Dr. Chowdhury began his presentation by emphasizing that muscle-invasive bladder cancer (MIBC) ...
The latest findings, published in the medical journal BMJ, show a "substantial" link between certain anticholinergic drugs ...
Cycling Weekly on MSN20h
Cycling and your pelvic floor: What every rider needs to knowCycling is an incredible sport with numerous health benefits, but spending long hours in the saddle can take a toll on an often-overlooked part of the body—the pelvic floor. This network of muscles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback